CMV seropositivity in older adults changes T cell functionality, but does not prevent antibody or cellular SARS-CoV-2 vaccine responses
Breznik, J. A.; Huynh, A.; Zhang, A.; Bilaver, L.; Bhakta, H.; Stacey, H. D.; Ang, J. C.; Bramson, J. L.; Nazy, I.; Miller, M. S.; Denburg, J.; Costa, A. P.; Bowdish, D. M. E.; COVID-in-LTC Study Group,
Show abstract
Chronic infection with human cytomegalovirus (CMV) may contribute to poor vaccine efficacy in older adults. We assessed effects of CMV serostatus on antibody quantity and quality, as well as cellular memory recall responses, after 2 and 3 SARS-CoV-2 mRNA vaccine doses, in older adults in assisted living facilities. CMV serostatus did not affect anti-Spike and anti-RBD IgG antibody levels, nor neutralization capacity against wildtype or beta variants of SARS-CoV-2 several months after vaccination. CMV seropositivity altered T cell expression of senescence-associated markers and increased TEMRA cell numbers, as has been previously reported; however, this did not impact Spike-specific CD4+ T cell memory recall responses. CMV seropositive individuals did not have a higher incidence of COVID-19, though prior infection influenced humoral immunity. Therefore, CMV seropositivity may alter T cell composition but does not impede the durability of humoral protection or cellular memory responses after SARS-CoV-2 mRNA vaccination in older adults. Key PointsCMV seropositive older adults have more EMRA and terminally differentiated T cells CMV seropositivity does not prevent antibody maintenance after SARS-CoV-2 vaccination CMV seropositivity does not impede SARS-CoV-2 vaccine T cell memory recall responses
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Influence of age, sex, body habitus, vaccine type and anti-S serostatus on cellular and humoral responses to SARS-CoV-2 vaccination 96%
- Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy 95%
- Sex-specific effects of aging on the humoral immune response to repeat vaccination with the high-dose seasonal influenza vaccine in older adults 95%
Similar papers in this journal
Similar papers in this journal
- Comparison of Omicron Breakthrough Infection Versus Monovalent SARS-CoV-2 Intramuscular Booster Reveals Differences in Mucosal and Systemic Humoral Immunity 95%
- Cellular and Transcriptional Signature of the Nasal Mucosa is Associated with Susceptibility to Pneumococcal Carriage in Older Adults 93%
- Spike-specific T cells are enriched in breastmilk following SARS-CoV-2 mRNA vaccination 92%
Similar papers in this journal
- Impact of SARS-CoV-2 vaccination on systemic immune responses in people living with HIV 95%
- SARS-CoV-2 naïve and recovered individuals show qualitatively different antibody responses following mRNA vaccination 95%
- Longitudinal cellular and humoral immune responses following Covid-19 BNT162b2-mRNA-based booster vaccination of craft and manual workers in Qatar. 95%
Similar papers in this journal
- COVID-19 convalescents exhibit deficient humoral and T cell responses to variant of concern Spike antigens at 12 month post-infection 96%
- GRAd-COV2 vaccine provides potent and durable immunity in randomised placebo-controlled phase 2 trial (COVITAR) 95%
- Rewired type I IFN signaling is linked to age-dependent differences in COVID-19 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.